|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 14/135 | (2006.01) |
| (11) | Number of the document | 3275892 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17191721.4 |
| Date of filing the European patent application | 2012-05-14 | |
| (97) | Date of publication of the European application | 2018-01-31 |
| (45) | Date of publication and mention of the grant of the patent | 2020-01-08 |
| (46) | Date of publication of the claims translation | 2020-04-10 |
| (30) | Number | Date | Country code |
| 201161486005 P | 2011-05-13 | US |
| (72) |
SWANSON, Kurt, US
CARFI, Andrea, US
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Struktūros prieš suliejimą RSV F antigenai |
| PRE-FUSION RSV F ANTIGENS |
| Payment date | Validity (years) | Amount | |
| 2020-04-29 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-05-14 |